T3D Therapeutics: Funding, Investors & Team (Oct 2026)
T3D Therapeutics is a developer of a novel drug therapy intended to stop or reverse the course of Alzheimer's disease. The company's drug is an orally-delivered once-a-day medicine that targets both the brain 'starvation' and neurodegeneration of Alzheimer's disease and helps in treating multiple manifestations of the disease, providing Alzheimer patients with a drug to potentially improve multiple defects and improve memory, motor function and cognition. T3D Therapeutics is based in Durham, North Carolina, and was founded in 2013.
T3D Therapeutics has raised $6.0M across 1 funding round on record, the most recent an undisclosed round of $6.0M announced in Sep 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
T3D Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2022.
T3D Therapeutics Funding Rounds
T3D Therapeutics Founders and Leadership Team
Contact details for the T3D Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →T3D Therapeutics Funding Compared to Other Biotechnology Startups
T3D Therapeutics' latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like T3D Therapeutics in Biotechnology and Durham
Companies Similar to T3D Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
T3D Therapeutics Funding FAQs
What does T3D Therapeutics do?
T3D Therapeutics is a developer of a novel drug therapy intended to stop or reverse the course of Alzheimer's disease. The company's drug is an orally-delivered once-a-day medicine that targets both the brain 'starvation' and neurodegeneration of Alzheimer's disease and helps in treating multiple manifestations of the disease, providing Alzheimer patients with a drug to potentially improve multiple defects and improve memory, motor function and cognition. T3D Therapeutics is based in Durham, North Carolina, and was founded in 2013.
How much funding has T3D Therapeutics raised?
T3D Therapeutics has raised $6.0M across 1 round on record. The most recent is an undisclosed round of $6.0M announced in Sep 2022.
When did T3D Therapeutics last raise funding?
T3D Therapeutics' most recent funding round on record is an undisclosed round of $6.0M, announced in Sep 2022.
Who is the CEO of T3D Therapeutics?
John Didsbury is listed as CEO at T3D Therapeutics.
Where is T3D Therapeutics headquartered?
T3D Therapeutics is based in Durham, North Carolina, United States.
How many employees does T3D Therapeutics have?
T3D Therapeutics is in the 1-10 employee band.
How does T3D Therapeutics' funding compare to other Biotechnology startups?
T3D Therapeutics' latest round of $6.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's T3D Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for T3D Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.